Advertisement

Month: July 2012

Drug Approved for Parkinson’s & RLS

The FDA has approved the rotigotine transdermal system (Neupro, UCB) for signs and symptoms of advanced stage idiopathic Parkinson’s disease (PD) and for treating moderate-to-severe primary restless legs syndrome, or RLS. The...

Read More

A Look Back at Mortality Rates

A report from the CDC has found that the age-adjusted risk of dying decreased 60% from 1935 to 2010. The report, available at www.cdc.gov/nchs, reviewed changes in causes of death, risk of dying, the gender gap in death rates,...

Read More

Immunotherapy for Autoimmune Epilepsy

A small observational study suggests that initiating immunotherapy early may improve seizure outcome in patients with medically intractable epilepsy for whom clinical and serological clues suggest an autoimmune basis. At an...

Read More

Complications & Collateral Damage

“Collateral damage: the effect of patient complications on the surgeon’s psyche” was a brief but interesting paper that probably went unnoticed by many. Using the results of a survey completed by only 123 of...

Read More

Discharge Planning in Poorly Controlled Diabetes

A multicenter, retrospective study of patients with poorly controlled diabetes who have been hospitalized at least once has found that just 22.4% received a change in outpatient diabetes therapy upon discharge. Patients were...

Read More

A New Device for GERD

A single-use, surgical device (Linx Reflux Management System, Torax Medical) has been approved by the FDA to treat symptoms associated with GERD. The device is indicated for patients who continue to experience symptoms despite...

Read More

Reviewing Tuberculosis Trends

A CDC report has found that 10,521 new tuberculosis (TB) cases were reported in 2011 in the United States, a 6.4% lower rate than was observed in 2010. The report, available at www.cdc.gov/mmwr, summarizes 2011 TB surveillance...

Read More

Statin Use May Reduce Parkinson’s Risk

A small prospective analysis suggests that statin use appears to modestly reduce the risk of Parkinson’s disease (PD). Researchers in Boston found that the relative risk of PD among statin users was 0.74 when compared with...

Read More

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage